Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jun Kawashima

Showing results (51-60 of 102) with videos related to

Pageof 11
Sort By:
HPB : the Official Journal of the International Hepato Pancreato Biliary Association|June 10, 2025
Oncologic impact of perineural invasion in perihilar cholangiocarcinoma: an international multicenter studyJun Kawashima, Miho Akabane, Diamantis I Tsilimigras, et al.
Surgery|April 9, 2026
Machine learning-based clustering differentiates bilateral hepatocellular carcinoma characteristics and prognosisYutaka Endo, Jun Kawashima, Odysseas Chatzipanagiotou, et al.
Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract|July 3, 2025
Nutritional status as a potential modulator of tumor morphology relative to disease-free survival: the role of Geriatric Nutritional Risk Index among patients with colorectal liver metastasesAndrea Baldo, Miho Akabane, Jun Kawashima, et al.
International Journal of Hematology|July 21, 2025
Efficacy and safety of momelotinib in Janus kinase inhibitor-experienced Asian patients with myelofibrosis and anemiaSung-Soo Yoon, Chih Cheng Chen, Sung-Eun Lee, et al.
Journal of Surgical Oncology|July 12, 2025
The Role of KRAS Status Among Patients Undergoing Staged Versus Simultaneous Resection for Synchronous Colorectal Liver MetastasesAndrea Baldo, Odysseas P Chatzipanagiotou, Jun Kawashima, et al.
Blood Advances|April 12, 2023
Momelotinib long-term safety and survival in myelofibrosis: integrated analysis of phase 3 randomized controlled trialsSrdan Verstovsek, Ruben Mesa, Vikas Gupta, et al.
Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract|February 14, 2024
Predicting risk of recurrence after resection of stage I intrahepatic cholangiocarcinomaJun Kawashima, Kota Sahara, Feng Shen, et al.
Ejhaem|February 26, 2024
Changes in bone marrow fibrosis during momelotinib or ruxolitinib therapy do not correlate with efficacy outcomes in patients with myelofibrosisStephen T Oh, Srdan Verstovsek, Vikas Gupta, et al.
Surgery|November 28, 2025
Clinicopathologic characteristics, genomic signatures, and outcomes of patients undergoing resection for early- versus late-onset colorectal liver metastasisDiamantis I Tsilimigras, Ioannis Ntanasis-Stathopoulos, Odysseas P Chatzipanagiotou, et al.
Surgery|December 2, 2025
Survival benefit of adjuvant chemotherapy for perihilar cholangiocarcinoma: Impact of log odds of metastatic lymph node countJun Kawashima, Miho Akabane, Odysseas P Chatzipanagiotou, et al.
Pageof 11

Showing results (51-60 of 102) with videos related to

Sort By:
Pageof 11
HPB : the Official Journal of the International Hepato Pancreato Biliary Association|June 10, 2025
Oncologic impact of perineural invasion in perihilar cholangiocarcinoma: an international multicenter studyJun Kawashima, Miho Akabane, Diamantis I Tsilimigras, et al.
Surgery|April 9, 2026
Machine learning-based clustering differentiates bilateral hepatocellular carcinoma characteristics and prognosisYutaka Endo, Jun Kawashima, Odysseas Chatzipanagiotou, et al.
Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract|July 3, 2025
Nutritional status as a potential modulator of tumor morphology relative to disease-free survival: the role of Geriatric Nutritional Risk Index among patients with colorectal liver metastasesAndrea Baldo, Miho Akabane, Jun Kawashima, et al.
International Journal of Hematology|July 21, 2025
Efficacy and safety of momelotinib in Janus kinase inhibitor-experienced Asian patients with myelofibrosis and anemiaSung-Soo Yoon, Chih Cheng Chen, Sung-Eun Lee, et al.
Journal of Surgical Oncology|July 12, 2025
The Role of KRAS Status Among Patients Undergoing Staged Versus Simultaneous Resection for Synchronous Colorectal Liver MetastasesAndrea Baldo, Odysseas P Chatzipanagiotou, Jun Kawashima, et al.
Blood Advances|April 12, 2023
Momelotinib long-term safety and survival in myelofibrosis: integrated analysis of phase 3 randomized controlled trialsSrdan Verstovsek, Ruben Mesa, Vikas Gupta, et al.
Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract|February 14, 2024
Predicting risk of recurrence after resection of stage I intrahepatic cholangiocarcinomaJun Kawashima, Kota Sahara, Feng Shen, et al.
Ejhaem|February 26, 2024
Changes in bone marrow fibrosis during momelotinib or ruxolitinib therapy do not correlate with efficacy outcomes in patients with myelofibrosisStephen T Oh, Srdan Verstovsek, Vikas Gupta, et al.
Surgery|November 28, 2025
Clinicopathologic characteristics, genomic signatures, and outcomes of patients undergoing resection for early- versus late-onset colorectal liver metastasisDiamantis I Tsilimigras, Ioannis Ntanasis-Stathopoulos, Odysseas P Chatzipanagiotou, et al.
Surgery|December 2, 2025
Survival benefit of adjuvant chemotherapy for perihilar cholangiocarcinoma: Impact of log odds of metastatic lymph node countJun Kawashima, Miho Akabane, Odysseas P Chatzipanagiotou, et al.
Pageof 11